Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin to Enhance Engraftment in UCB Transplant
NCT01720264Phase 2Completed
- Start
- Nov 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sitagliptin in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), chronic myeloid leukemia (CML), non-Hodgkin lymphoma (NHL). Started Nov 2012; status: completed.
02
Drugs
sitagliptin
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)myelodysplastic syndrome (MDS)chronic myeloid leukemia (CML)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01720264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01720264.